ΕΛ.Ι.Ε.Κ.

Δημοσιεύσεις 2013

PROGNOSTIC SIGNIFICANCE OF RACGAP1 MRNA EXPRESSION IN HIGH-RISK EARLY BREAST CANCER.A HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG) STUDY

K. Pliarchopoulou, K.T. Kalogeras, R. Kronenwett, R.M. Wirtz, A.G. Eleftheraki, A. Batistatou, M. Bobos, N. Soupos, G. Polychronidou, H. Gogas, E. Samantas, C. Christodoulou, T. Makatsoris, N. Pavlidis, D. Pectasides, G. Fountzilas

Cancer Chemother Pharmacol. 2013 Jan;71(1):245-55. doi: 10.1007/s00280-012-2002-z

INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R) EXPRESSION AND SURVIVAL IN OPERABLE SQUAMOUS-CELL LARYNGEAL CANCER

G. Mountzios, I. Kostopoulos, V. Kotoula, I. Sfakianaki, E. Fountzilas, K. Markou, I. Karasmanis, S. Levva, N. Angouridakis, K. Vlachtsis, A. Nikolaou, J. Constantinidis, G. Fountzilas

PLoS One. 2013;8(1):e54048. doi: 10.1371/journal.pone.005404

EXPRESSION PROFILING OF 21 BIOMOLECULES IN LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMAS OF CAUCASIAN PATIENTS

D. Krikelis, M. Bobos, G. Karayannopoulou, L. Resiga, S. Chrysafi, E. Samantas, D. Andreopoulos, V. Vassiliou, E. Ciuleanu, G. Fountzilas G

BMC Clin Pathol. 2013 Jan 29;13:1. doi: 10.1186/1472-6890-13-1

SAMPLE PARAMETERS AFFECTING THE CLINICAL RELEVANCE OF RNA BIOMARKERS IN TRANSLATIONAL BREAST CANCER RESEACH

V. Kotoula, K.T Kalogeras, G. Kouvatseas, D. Televantou, R. Kronenwett, R.M Wirtz, G. Fountzilas

Virchows Arch. 2013 Feb;462(2):141-54. doi: 10.1007/s00428-012-1357-1.

BIOMARKERS OF BENEFIT FROM CETUXIMAB-BASED THERAPY IN METASTATIC COLORECTAL CANCER: INTERACTION OF EGFR LIGAND EXPRESSION WITH RAS/RAF, PIK3CA GENOTYPES

G. Pentheroudakis, V. Kotoula, W. De Roock, G. Kouvatseas, P. Papakostas, T. Makatsoris, D. Papamichael, I. Xanthakis, J. Sgouros, D. Televantou, G. Kafiri, A.C. Tsamandas, E. Razis, E. Galani, D. Bafaloukos, I. Efstratiou, I. Bompolaki, D. Pectasides, N. Pavlidis, S. Tejpar, G. Fountzilas

BMC Cancer. 2013 Feb 2;13:49. doi: 10.1186/1471-2407-13-49

CYCLIN D1, EGFR, AND Akt/mTOR PATHWAY. POTENTIAL PROGNOSTIC MARKERS IN LOCALIZED LARYNGEAL SQUAMOUS CELL CARCINOMA

D. Dionysopoulos, K. Pavlakis, V. Kotoula, E. Fountzilas, K. Markou, I. Karasmanis, N. Angouridakis, A. Nikolaou, K.T Kalogeras, G. Fountzilas

Strahlenther Onkol. 2013 Mar;189(3):202-14. doi: 10.1007/s00066-012-0275-0

EVALUATION OF THE PROGNOSTIC ROLE OF CENTROMERE 17 GAIN AND HER2/TOPOISOMERASE II ALPHA GENE STATUS AND PROTEIN EXPRESSION IN PATIENTS WITH BREAST CANCER TREATED WITH ANTHRACYCLINE-CONTAINING ADJUVANT CHEMOTHERAPY: POOLED ANALYSIS OF TWO HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) PHASE III TRIALS

G. Fountzilas, U. Dafni, M. Bobos, V. Kotoula, A. Batistatou, I. Xanthakis, C. Papadimitriou,
I. Kostopoulos, T. Koletsa, E. Tsolaki, D. Televantou, E. Timotheadou, A. Koutras, G. Klouvas, E. Samantas, N. Pisanidis, C. Karanikiotis, I. Sfakianaki, N. Pavlidis, H. Gogas, H. Linardou, K.T Kalogeras KT, D. Pectasides, M.A Dimopoulos

BMC Cancer. 2013 Mar 28;13:163. doi: 10.1186/1471-2407-13-163

PREVALENCE OF BRCA1 MUTATIONS IN FAMILIAL AND SPORADIC GREEK OVARIAN CANCER CASES

A.V Stavropoulou, F. Fostira, M. Pertesi, M. Tsitlaidou, G.E Voutsinas, O. Triantafyllidou, A. Bamias, M.A Dimopoulos, E. Timotheadou, D. Pectasides, C. Christodoulou, G. Klouvas, C. Papadimitriou, T. Makatsoris, G. Pentheroudakis, G. Aravantinos, V. Karydakis, D. Yannoukakos, G. Fountzilas, I. Konstantopoulou

PLoS One. 2013;8(3):e58182. doi: 10.1371/journal.pone.0058182 (Epub 2013 Mar 11)

DARPP32, STAT5 AND STAT3 mRNA EXPRESSION RATIOS IN GLIOBLASTOMAS ARE ASSOCIATED WITH PATIENT OUTCOME

D. Televantou, G. Karkavelas, P. Hytiroglou, S. Lampaki, Iliadis G, Selviaridis P, Polyzoidis KS,
G. Fountzilas, V. Kotoula

Pathol Oncol Res. 2013 Apr;19(2):329-43. doi: 10.1007/s12253-012-9588-7 (Epub 2012 Dec 20)

EVALUATION OF CURRENT PROGNOSTIC AND PREDICTIVE MARKERS IN BREAST CANCER: A VALIDATION STUDY OF TISSUE MICROARRAYS

A. Batistatou, D. Televantou, M. Bobos, A.G Eleftheraki, E. Kouvaras, S. Chrisafi, G.K Koukoulis, V. Malamou-Mitsi, G. Fountzilas

Anticancer Res. 2013 May;33(5):2139-45

IXABEPILONE ADMINISTERED WEEKLY OR EVERY THREE WEEKS IN HER2-NEGATIVE METASTATIC BREAST CANCER PATIENTS; A RANDOMIZED NON-COMPARATIVE PHASE II TRIAL

G. Fountzilas, V. Kotoula, D. Pectasides, G. Kouvatseas, E. Timotheadou, M. Bobos, X. Mavropoulou, C. Papadimitriou, E. Vrettou, G. Raptou, A. Koutras, E. Razis, D. Bafaloukos, E. Samantas, G. Pentheroudakis, D.V. Skarlos

PLoS One. 2013 Jul 23;8(7):e69256. doi: 10.1371/journal.pone.0069256.

PROGNOSTIC SIGNIFICANCE OF ESR1 GENE AMPLIFICATION, mRNA/PROTEIN EXPRESSION AND FUNCTIONAL PROFILES IN HIGH-RISK EARLY BREAST CANCER: A TRANSLATIONAL STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)

G. Pentheroudakis, V. Kotoula, A.G. Eleftheraki, E. Tsolaki, R.M. Wirtz, K.T. Kalogeras, A. Batistatou, M. Bobos, M.A. Dimopoulos, E. Timotheadou, H. Gogas, C. Christodoulou, K. Papadopoulou, I. Efstratiou, C.D Scopa, I. Papaspyrou, D. Vlachodimitropoulos, H. Linardou, E. Samantas, D. Pectasides, N. Pavlidis, G. Fountzilas

PLoS One. 2013 Jul 29;8(7):e70634. doi: 10.1371/journal.pone.0070634.

THE PROGNOSTIC ROLE OF EPHRIN A2 AND ENDOTHELIAL GROWTH FACTOR RECEPTOR PATHWAY MEDIATORS IN PATIENTS WITH ADVANCED COLORECTAL CANCER TREATED WITH CETUXIMAB

A. Strimpakos, G. Pentheroudakis, V. Kotoula, W. De Roock, G. Kouvatseas, P. Papakostas,T. Makatsoris, D. Papamichael, A. Andreadou, J. Sgouros, A. Zizi-Sermpetzoglou, A. Kominea, D. Televantou, E. Razis, E. Galani, D. Pectasides, S. Tejpar, K. Syrigos, G. Fountzilas

Clin Colorectal Cancer. 2013 Dec;12(4):267-274.e2. doi: 10.1016/j.clcc.2013.07.001.

THE PROGNOSTIC SIGNIFICANCE OF WNT PATHWAY IN SURGICALLY-TREATED COLORECTAL CANCER: β-CATENIN EXPRESSION PREDICTS FOR DISEASE-FREE SURVIVAL

K. Kamposioras, A. Konstantara, V. Kotoula, S. Lakis, G. Kouvatseas, E. Akriviadis, E. Vrettou, D. Dionysopoulos, D. Krikelis, K. Papadopoulou, E. Charalambous, S. Chrisafi, C. Konstantaras, G. Fountzilas

Anticancer Res. 2013 Oct;33(10):4573-84

VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS AND CLINICAL OUTCOME IN PATIENTS WITH METASTATIC BREAST CANCER TREATED WITH WEEKLY DOCETAXEL

A.K. Koutras, V. Kotoula, C. Papadimitriou, D. Dionysopoulos, F. Zagouri, H.P. Kalofonos,H.P. Kourea, D.V. Skarlos, E. Samantas, K. Papadopoulou, P. Kosmidis, D. Pectasides, G. Fountzilas

Pharmacogenomics J. 2013 Sep 24. doi: 10.1038/tpj.2013.36.

IDENTIFICATION AND VALIDATION OF A MULTIGENE PREDICTOR OF RECURRENCE IN PRIMARY LARYNGEAL CANCER

E. Fountzilas, V. Kotoula, N. Angouridakis, I. Karasmanis, R.M. Wirtz, A.G. Eleftheraki, E. Veltrup, K. Markou, A. Nikolaou, D. Pectasides, G. Fountzilas

PLoS One. 2013 Aug 9;8(8):e70429. doi: 10.1371/journal.pone.0070429.